Bagger-Sørensen & Co.

Bagger-Sørensen & Co. is a prominent Danish family-owned holding company with a legacy of innovation in the confectionery and healthcare industries. The group gained global recognition for developing Fertin Pharma, a world leader in medicated chewing gum and nicotine replacement therapy (NRT), which was sold to Philip Morris International in 2021. Today, the company operates as an active investor and incubator, focusing on oral delivery technologies for active ingredients in the pharmaceutical and wellness sectors. Its portfolio includes ventures in CBD delivery, functional confectionery, and specialized investment management. The group continues to leverage its expertise in intra-oral delivery to support life science companies and consumer health brands.